FDA Adverse Event Injury Summary report: N

TELIGEN

MDR report key: 2040718 · Received April 6, 2011

Report

Report Number
2124215-2011-00856
Event Type
Injury
Date Received
April 6, 2011
Date of Event
December 7, 2009
Report Date
January 10, 2011
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) AND RIGHT VENTRICULAR (RV) DEFIBRILLATION LEAD HAD AN INCREASE IN PACING IMPEDANCES AND A RISE IN PACING THRESHOLD MEASUREMENTS. THIS WOULD ONLY OCCUR DURING POCKET MANIPULATION AND WHEN THE PATIENT SAT IN CERTAIN POSITIONS. APPROXIMATELY ONE YEAR LATER, THE PACING IMPEDANCE MEASUREMENTS INCREASED TO GREATER THAN 2,000 OHMS. THERE WAS ALSO NOISE OBSERVED ON THE RV RATE/SENSE CHANNEL AND SHOCK ELECTROGRAM WITH POCKET MANIPULATION. THIS DID NOT RESULT IN ANY PACING INHIBITION AND THE PATIENT WAS NOT PACEMAKER DEPENDENT. A REVISION PROCEDURE TOOK PLACE AND THE RV LEAD WAS TESTED THROUGH THE PACING SYSTEM ANALYZER (PSA). ALL LEAD MEASUREMENTS WERE WITHIN NORMAL RANGE. THE LEAD WAS RECONNECTED TOT HE DEVICE AND MEASUREMENTS RETURNED TO NORMAL RANGE. THERE WAS SUSPICION OF A SET SCREW ISSUE. THE DEVICE AND LEAD REMAIN IN SERVICE WITHOUT FURTHER COMPLICATION. TO DATE, THERE HAVE BEEN NO ADVERSE PATIENT EFFECTS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 48 YR Required Intervention 0157| E110| 4469